In an article in the 8th December 2011 issue of the French newspaper Libération, Philippe Cayla, a former French civil servant who is currently President of Euronews Development, invited readers to join him in initiating a European Citizens Initiative which proposes that the European Union adopt a rule that all EU citizens living in another EU state than that of their nationality (so-called ‘se...

BACKGROUND Factors that influence smoking initiation and age of smoking onset are important considerations in tobacco control. We evaluated European Union (EU)-wide differences in the age of onset of regular smoking, and the potential role of peer, parental and tobacco product design features on the earlier onset of regular smoking among adults <40 years old in 27 EU countries. METHODS We ana...

The volume of direct British aid to Africa is constrained by the substantial level of its contributions to multilateral programmes (including those of the EU). The multilateral agencies, of course, also provide large volumes of aid to Sub-Saharan Africa, of which the UK finances its share, but the following discussion is restricted to the bilateral element in British aid to Africa. The share of...

The EU directives on air quality force member states to inform the public on the status of the ambient air quality. The Internet is commonly used for this purpose and often air quality is being presented as an index ranging from good to bad. A review of existing websites and air quality indices shows that the way air quality is interpreted differs considerably. The paper presents a new air qual...

Many new challenges have arisen for Slovenia as a full member of the EU from May 2004, and also many opportunities. On the one hand we have some successful economic players who can definitely gain from the new opportunities. On the other hand some structural changes still have to be accomplished. Among all of them one of the most demanding tasks is related to the higher educational system relat...

In the fast-moving world of personalised medicine there are many issues and barriers-not least when it comes to getting novel drugs and treatments swiftly to where they are really needed. Slow bench-to-bedside rates do not help the 500 million potential patients across the EU's current 28 Member States, and the timings are affected by several elements during the development and licensing phases...